Inequalities in prescribing of secondary preventive therapies for ischaemic heart disease in Ireland

Irish Medical Journal

Volumn 95, Issue 6, 2002, Pages 169-172

  Bennett, K E ^a   Williams, D ^a   Feely, J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGE; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; DATA BASE; FEMALE; GENDER; GEOGRAPHY; HEALTH CARE NEED; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; SECONDARY PREVENTION; STATISTICAL ANALYSIS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; ASPIRIN; DRUG UTILIZATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IRELAND; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; SEX FACTORS;

EID: 0036627105     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Department of Health and Children. Building healthier hearts: A report of the cardiovascular health strategy group. March 1999.
2. years of Heart Disease in Ireland. Mortality, morbidity and Health Services Implications. Irish Heart Foundation. Feb 2001.
3. Woods KL, Ketley D, Agusti A, Hagn C, Kala R, Karatzas NB et al. Use of coronary angiography and revascularisation procedures following acute myocardial infarction. A European perspective. Eur Heart J. 1998 Sept; 19(9): 1274-6.
4. Hannan EL, Kumar D. Geographic variation in the utilisation and choice of procedures for treating coronary artery disease in New York State. Ischaemic Heart Disease Patient Outcomes Research Team (PORT). J. Health Serv Res Policy. 1997; 2: 137-43.
5. Steingart R, Packer M, Hamm P, Coglianese M, Gersh B, Geltman E et al. Sex differences in the management of coronary artery disease. NEJM 1991;325:226-30.
6. Malone M, Sial S, Battiiola R, Nachodsky J, Solomon D, Goodwin J. Age-related differences in the utilisation of therapies post acute myocardial infarction. J. Am. Geriatric. Soc 1995;43:627-33.
7. Pyorala K, De Backer G, Graham I, Poole-Wilson PA, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of Task force of the European Society of Cardiology, European Artherosclerosis Society and European Society of Hypertension. Eur. Heart J . 1994; 15:1300-31.
8. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice: recommendations of second Joint Task Force of European and other societies on coronary prevention. Eur Heart J 1998; 19:1434-1503.
9. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-1: prevention of death, myocardial infarction, and stroke, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
10. Teo K, Yusuf S, Furberg C. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993;270:1589-95.
11. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an Angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. NEJM 2000;342:145-53.
12. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with CHD: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
13. EUROASPIRE I and II group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001.
14. Cohen J. ABC of secondary prevention of CHD: easier said than done. Lancet 2001;357: 972-973.
15. Majeed A, Moser K. Age, sex and practice variations in the use of statins in general practice in England and Wales. J. Pub H Med.22; 275-279.
16. Feely J. The influence of pharmacoeconomic factors on prescribing patterns in Ireland. Pharmacoeconomics. 1992; 2: 99-106.
17. Cannon P, Connell P, Stockley I, Garner S. Prevalence of angina as assesses by a survey of prescriptions for nitrates. Lancet 1998;1:979-81.
18. McPherson K, Wennberg JE, Hovind OB, Clifford P. Small-area variations in the use of common surgical procedures: an international comparisons of New England, England and Norway. NEJM; 21:1310-1314.
19. Jones MI, Greenfield SM. Bradley CP. Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ: 323: 1-7.
20. Baxter C, Jones R, Corr L. Time trend analysis and variations in prescribing lipid lowering drugs in general practice. BMJ 1998;317:1134-35.
21. Feely J, Chan R, McManus J, O'Shea B. The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics, 1999;16: 175-181.
22. Tomlin Z, Humphrey C, Rogers S. General Practitioners' perceptions of effective health care. BMJ. 1999; 318:1532-1535.
23. Roberts E, Norris P. Regional variation in anti-depressant dispensings in New Zealand: 1993-1997. N Z Med J. 200 1;114:27-30.
24. Williams D, Feely J. Co-prescribing with nitrate therapy shows neglect in secondary prevention. In Proceedings of British Pharmacology Society Meeting. September 2000. Br J Pharmacol 2000; 131 Suppl: I-iv.
25. Wenger N. Coronary heart disease: an older woman's major health risk. BMJ 1997;315:1085-90.
26. McLaughlin T, Soumerai S, Willison D, Gurwitz J, Borbas C, Guadagnoli E et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: Evidence for under treatment in women and the Elderly. Arch.Intern.Med 1996;156:799-805.
27. Hippisley-Cox J, Pringle M, Crown N, Meal A. Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ; 2001;322;
28. Tobin J, Wassertheil-Smoller S, Wexler J, et al. Sex bias in considering coronary bypass surgery. Ann.Intern.Med 1987;107:19-25.
29. Lye M, Donnellan C. Heart Disease in the elderly. Heart 2000;84:560-6.
30. Bugeja G, Kumar A, Banerjee A. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315:1059.
31. Thiru K, Gray J, Majeed A. Management of Ischaemic Heart Disease in primary care: towards better practice. J. Pub H Med. 1999;21:179-184.
32. Campbell NC, Thain J, Georges Dean H, Ritchie LD, Rawles M. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ. 1998;316:1430-1434.
33. Fairhurst K, Huby G. From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia. BMJ: 1998; 317: 1130-4
34. Feely, J. The therapeutic gap - Compliance with medication and guidelines. Atherosclerosis. 1999; 147: S31-7.